🇺🇸 FDA
Patent

US 7297488

Identifying and testing antisense oligonucleotides that inhibit telomerase reverse transcriptase

granted A61KA61K38/00A61K39/00

Quick answer

US patent 7297488 (Identifying and testing antisense oligonucleotides that inhibit telomerase reverse transcriptase) held by The Regents of the University of Colorado expires Mon Nov 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Nov 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/00, A61K39/00, A61K48/00